Higher levels of IL-6 have also been shown to correlate with osteoporosis and other bone deficits in patients with chronic inflammatory diseases such as rheumatoid arthritis [53] and inflammatory bowel disease [54], as well as patients who underwent HCT [55-59]. Here, IL6 is linked to osteoporosis.